World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

QUALITY OF LIFE AMONG PATIENTS ON HEMODIALYSIS

Dr. Aimen Ali*, Dr. Tooba Ali and Dr. Aroosh Mahmood

ABSTRACT

Objective: To assess health-related quality of life and co-morbidity pattern in hemodialysis patients Methods: By a nonprobability purposive sampling procedure, 123 hemodialysis patients from our hemodialysis center in Jinnah Hospital Lahore were interviewed by resident doctor according to the SF-36 Scales. The means and standard deviations for each of eight scales were calculated, each domain ranges from 0-100, the highest scores indicating better quality of life. Comorbidities like DM, Hypertension, ischemic heart disease lung disease etc. were also recorded. Results: The scores of the eight scales in the hemodialysis patients were 49.92 ±30.90, 38.82 ±41.39, 46.73 ±26.54, 40.52 ± 21.65, 43.98 ±21.82, 49.43 ±27.76, 49.85 ±40.59 and 59.93 ±17.36. Co-morbidities pattern were hypertension in 104(84.6%), DM 59(48%), ischemic heart disease 23(18.7%) and other co morbidities were less common. The scores of most of the scale in the patients with co morbidities were lower as compared to patients without co morbidities. Data obtained was entered by a doctor in SPSS version 20 and was analyzed to compute descriptive statistics of the numerical variables while frequencies and their percentages for categorical variables of the study. Conclusion: The results of our study indicate that quality of life was poor among patients on hemodialysis particularly those having co-morbidities. Hypertension and diabetes were major co-morbidities in our study. Quality of life score was lower in female patients than that of male patients. Proper management of comorbidities can improve quality of life of these patients which will decrease disease morbidity and mortality. This will also provide psychological and financial relief to the suffering families and also be cost effective for hospital authorities in terms of availability of space.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR